HISUN(SH:600267) Zheng Quan Shi Bao Wang·2025-11-19 09:18Core Viewpoint - Haizheng Pharmaceutical (600267) announced the establishment of a wholly-owned subsidiary, Haizheng Animal Health, to invest in a pet prescription food project in Taizhou, Zhejiang Province, with a total investment of 200 million yuan [1] Company Summary - The company plans to use its own funds of 100 million yuan for the project [1] - The project will be implemented in two phases, with the first phase having a construction period of 24 months [1] - Upon reaching full production capacity, the project is expected to add an annual production capacity of 10,000 tons of pet prescription food [1] Industry Summary - The investment in the pet prescription food sector indicates a strategic move to tap into the growing demand for specialized pet nutrition [1] - The establishment of the subsidiary and the project aligns with industry trends focusing on health and wellness in pet care [1]